CXCL9 and neoplasm: Given the increase in Cxcl9/10 mediated signals from mdTAMs following anti-PD-L1 treatment, we hypothesised that Cxcr3-expressing T cells would localise to the tumour core, where mdTAMs were enriched (Fig 2).